Fatal cardiovascular complication 19 years after treatment for fibrosarcoma.
Galloway
M
M
University College London.
MacLeod
D
D
Sheaff
M
M
Wedzicha
J
J
D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000628:therapy*; D017024:Chemotherapy, Adjuvant / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects*; D004719:Endomyocardial Fibrosis / Q000209:etiology*; D017809:Fatal Outcome; D005354:Fibrosarcoma / Q000628:therapy*; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000009:adverse effects; D011878:Radiotherapy / Q000009:adverse effects; D014750:Vincristine / Q000009:adverse effects
D000970:Antineoplastic Agents; D014750:Vincristine; D004317:Doxorubicin; D008727:Methotrexate